Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Rhythm Biosciences Ltd has reported a change in Director Trevor Lockett’s interests, with the expiry of unlisted options resulting in his direct interest in the company’s securities. Following the expiry of options, Lockett’s holdings in Rhythm Biosciences now consist of 1,678,300 ordinary shares and 193,650 listed options, while all unlisted options have lapsed.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.
